our
SPEAKERS
The XII Pan-American section congress will host plenary top-notch talks by prominent scientists and research presentations.
Distinguished Plenary Speaker
Professor Bruce Bean
Professor of Neurobiology at Harvard Medical School. Did his Ph.D. research in Biophysics at the University of Rochester studying neuronal sodium channels with Peter Shrager, did post-doctoral work in cardiac electrophysiology with Richard W. Tsien at Yale University Medical School, and has had previous faculty positions at the University of Iowa and at the Vollum Institute of Oregon Health Sciences University. His research interest is in the physiological function and pharmacology of ion channels, with a particular interest in using drugs and toxins as tools to understand how multiple ion channels control firing patterns of mammalian central neurons, to understand pathophysiology in disease states, including epilepsy, neuropathic pain, amyotrophic lateral sclerosis, and Parkinson ’s disease. During the last three years Dr. Bruce has been doing research in topics as: TRP channels as drug portals to block calcium channels and synaptic transmission, potassium channel and hyperexcitability screen for novel ALS therapeutics, selective targeting of sodium channel blockers to pain-sensing neurons, novel pain treatment development, and the mechanism of action of novel sodium channel inhibitors.
Confirmed Speakers
​
Andreas Hougaard Laustsen, Technical University of Denmak, Lyngby, Denmark
Andrew Walker, The University of Queensland, Brisbane, Australia
Angel Yanagihara, University of Hawaii, Manoa, HI, USA
Baldomero Olivera, Department of Biology, University of Utah, Salt Lake, Utah, USA
Baltazar Becerril, Instito de Biotecnología UNAM, Cuernavaca, Mexico
Bruno Lomonte, Instituto de Biomedicina de Valencia, Valencia, Spain
Carlos Alvarez, University of Havana, Havana, Cuba
Carl-Wilhelm Vogel, University of Hawaii Cancer Center, Honolulu, Hawaii, USA
Christie Wilcox, University of Hawaii, Manoa, HI, USA
Christina Schroeder, The University of Queensland Brisbane, Queensland, Australia
Craig Doupnik, University of South Florida, Tampa, FL, USA
David Adams, Health Innovations Research Institute, RMIT University, Melbourne, Victoria, Australia.
David Julius, Department of Physiology, UCSF School of Medicine, San Francisco, California, USA
Denise Tambourgi, Butantan Institute, Sao Paulo,
Francis Markland, University of Southern California, Los Angeles, California, USA
George Okeyo, Nanion Technologies, Inc., Livingston, New Jersey, USA
Gina D’Suze, Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela
Glenn King, Institute for Molecular Biosciences, The University of Queensland, St Lucia, Australia
Grahan M. Nicholson, Neurotoxin Research Group, School of Life Sciences, University of Technology Sydney, Australia
Hendrix Luesch, University of Florida, Gainesville, FL, USA
James Olson, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Jay Fox, University of Virginia School of Medicine, Charlottesville, VA, USA
Jeremiah Osteen, University of California, San Francisco, California, USA
Jon Sack, Department of Physiology and Membrane Biology, University of California, Davis, California, USA
Jonas Perales, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
José Gutierrez, Instituto Clodomiro Picado, Universidad de Costa Rica, San José, Costa Rica
Juan Calvete, Instituto de Biomedicina de Valencia, Valencia, Spain
Jian Payandeh, Genetech, California, USA
Jon Sack, University of California, Davis, California, USA
Julian White, Toxinology Dept., Women's & Children's Hospital, North Adelaide, Australia.
Justin Dubois, Stanford University, Stanford, CA, USA
Kate Baumannn,Venom Evolution Laboratory, School of Biological Sciences, University of Queensland, St Lucia, QLD 4072, Australia
Kenton Swartz, NINDS/NIH Bethesda, Maryland, USA
Lachlan Rash, The University of Queensland, St. Lucia, Australia
Lekhsan Othman, Monash University Malaysia, Malaysia
Leslie Boyer, University of Arizona Health Sciences, Tucson, AZ, USA
Manuela Pucca, Federal University of Roraima, Boa Vista, RR, Brazil
María Elena de Lima, Universidade Federal de Minas Gerais, Belo Horizote, Brazil
Mark Hamann, Department of Pharmacognosy and National Center for Natural Products Research, University of Mississippi, Mississippi, USA
Marymegan Daly, The Museum of Biological Diversity, Ohio State University, Ohio, USA
Matthew R. Lewin, Ophirex, Inc., Corte Madera, CA, USA
Mike Pennington, Peptides International, Louisville, Kentucky, USA
Nadine Kabbani, George Mason University, Faifax, VA, USA
Peter Oparin, M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
Ray Norton, Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Melbourne, Australia
Richard Lewis, Centre for Pain Research, Institute for Molecular Biosciences, The University of Queensland, St Lucia, Australia.
Samantha Nixon, University of Queensland, Brisbane, Australia
Samira Aili, University of Technology Sydney, Sydney, Australia
Stephen Mackessy, University of Northern Colorado, Colorado, USA
Tai Kubo, Natl Inst Advanced Ind Sci & Tech, Koto-ku, Japan
William Kem, University of Florida, Gainesville, Florida, USA
Yehu Moran, Hebrew University of Jerusalem, Jerusalem, Israel
​
​
​
Check back soon to find out more about our top-notch speakers at IST 2016